Goodbye or arrivederci?
Our new vocabulary gene, genome, molecular, targeted, personalised no longer inspires the confidence it once did, and as the cancer community prepares to gather at the 18th ECCO – 40th ESMO European Cancer [more]
Number 68
Our new vocabulary gene, genome, molecular, targeted, personalised no longer inspires the confidence it once did, and as the cancer community prepares to gather at the 18th ECCO - 40th ESMO European Cancer Congress in Vienna..... [ more ]
Denis Lacombe quietly orchestrating the clinical research revolution
The scientific complexity and economic cost of developing new cancer therapies demand a level of collaboration and sharing that takes both industry and academia well beyond their comfort zones. EORTC head Denis Lacombe believes he [more]
What can we learn from liquid biopsies?
Early detection, disease prognosis, a guide to treatment, a key to unlock the secrets of how cancers evolve. Researchers have high hopes for what they can learn from the biological detritus shed by primary tumours [more]
Asking the dumb questions
It took ten years of immersion in the world of cancer research to produce the book that won Clifton Leaf a Best Cancer Reporter Lifetime Achievement award. But it started from a simple question: how [more]
Does lack of physical exercise jeopardise a patient’s chances of survival?
Exercise reduces the risks of getting some cancers but what about after diagnosis? What should we be advising our patients? Be physically active in everyday life. Limit the time you spend sitting.” So says [more]
Championing healthcare in an age of austerity: an interview with the European Health Commissioner
Vytenis Andriukaitis talks to Cancer Worlds Anna Wagstaff about what Europe needs to do to safeguard and extend access to high-quality cancer care in challenging times. How can European countries provide a rapidly rising number [more]
Are progression-free and disease-free survival the new gold standard for cancer trials?
Showing that a new drug can keep advanced cancers from progressing, or stop early cancers from returning, is quicker, cheaper and easier than showing that it helps patients live longer. But how can we judge [more]
Rerouted, not derailed: resuming a young life after cancer
Paediatric oncologists are highly focused on how to minimise and manage the life-long damage their treatments inflict on young patients health. But for young survivors, the most immediate challenge is how to get an interrupted [more]
The moment medical students discover a profound appreciation for humanity
A great short piece by medical student Armaan Rowther flagging up the role of anatomy labs in shaping medics attitudes towards their future patients. “Is the language of medicine that is learned in anatomy lab [more]
Newsround
Elderly breast cancer patients do not benefit from radiotherapy => European Journal of Cancer Most elderly patients with pT1 breast cancer treated by quadrantectomy do not benefit from radiotherapy, the results of 15 years of [more]
... [ more ]